Conversely, Pgk1 overexpression, or treatment with terazosin (an FDA-approved small molecule that binds and activates Pgk1), rescued motor axon phenotypes in SMA zebrafish. This evidence concerns the gene PGK1 and proximal spinal muscular atrophy.